share_log

Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.03%),Deep Track Biotechnology Master Fund, Ltd.(9.03%), etc.

Dec 19, 2022 16:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more